Atea Pharmaceuticals
AVIR
$3.96
Share price
3.39%
Change (1 day)
18.92%
Change (1 year)
Categories
Atea Pharmaceuticals (AVIR) - P/B ratio
P/B ratio as of May 2024 : 0.5810
According to Atea Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.5810.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Atea Pharmaceuticals - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.4584 | -26.71% |
| 2022-12-31 | 0.6254 | -40.23% |
| 2021-12-31 | 1.05 | -83.4% |
| 2020-12-31 | 6.30 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | 392.99% | 🇺🇸 USA |